Dr. Virendra Joshi, MD
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Years since graduation
- 37
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 194
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
LA license MD.13642R · GA license 41590 · LA license 13642R
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Emory University Hospital Atlanta, GA
- Emory University Hospital Midtown Atlanta, GA
- Saint Joseph's Hospital of Atlanta, Inc Atlanta, GA
Medical groups
- The Emory Clinic Inc (3,568 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 194
- Services billed
- 561
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Telephone medical discussion with physician, 21-30 minutes | 179 | 87 |
| Telephone medical discussion with physician, 11-20 minutes | 69 | 49 |
| Established patient office or other outpatient visit, 20-29 minutes | 64 | 48 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 46 | 28 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 40 | 25 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 37 | 35 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 33 | 32 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 24 | 17 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | 23 | 23 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 19 | 19 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in New Orleans, LA | 299 |
| Sucralfate Other prescribers in New Orleans, LA | 97 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in New Orleans, LA | 94 |
| Dicyclomine Hcl Other prescribers in New Orleans, LA | 77 |
| Lactulose Other prescribers in New Orleans, LA | 58 |
| Linzess (linaclotide) Other prescribers in New Orleans, LA | 57 |
| Creon (lipase/protease/amylase) Other prescribers in New Orleans, LA | 56 |
| Ondansetron Odt (ondansetron) Other prescribers in New Orleans, LA | 47 |
| Peg-3350 And Electrolytes (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in New Orleans, LA | 33 |
| Pantoprazole Sodium Other prescribers in New Orleans, LA | 32 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $175 in total to this clinician.
| Cook Medical LLC | $175 |
|---|
| Food and Beverage | $175 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,020 in research payments for these studies, mostly to the institutions running them.
- A study of TAK-062 in treatment of active celiac disease in participants attempting a gluten-free diet
Takeda Pharmaceuticals U.S.A., Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.